BEIJING, March 26, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that Shanghai Concord Medical Imaging Diagnostic
Shanghai Concord Medical Imaging Diagnostic Center is an independent imaging diagnostic center jointly established by Concord Medical and GE Healthcare, located in Shanghai New Hongqiao International Medical Center ("Medical Center"). The equipment in the Imaging Center consists of GE's latest high-end products, and the quantity of equipment will gradually increase according to the amount of image inspections in the Medical Center. The Imaging Center is expected to introduce world-class diagnostic technology and management services, cover the Medical Center and the Yangtze River Delta region through a remote sharing consultation platform, and provide a full range of imaging diagnosis and high-quality services for domestic and foreign commercial insurance patients. The Imaging Center is expected to officially open before the end of 2018.
Dr. Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical, commented, "I am pleased that our first independent imaging diagnostic center, Shanghai Concord Medical Imaging Diagnostic Center, obtained an independent imaging diagnostic license after years of efforts. In the future, I hope artificial intelligence can be utilized in the Imaging Center to do early screening of cancer. The establishment of the Imaging Center is an important milestone in the overall strategic development of Concord Medical and is also in line with the direction of national healthcare reform, keeping pace with times. I believe that the Imaging Center will help more patients with world-class diagnostic technology."
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2017, the Company operated a network of 60 centers with 41 hospital partners that spanned 34 cities and 19 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
For more information, please contact:
Concord Medical ServicesMs. Carol TIAN (Chinese and English)+86 10 5903 6688 (ext. 608)email@example.com
View original content:http://www.prnewswire.com/news-releases/concord-medical-to-obtain-an-independent-imaging-diagnostic-license-300619225.html
SOURCE Concord Medical Services Holdings Limited
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All